参考文献/References:
[1] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013 年修订版)[J]. 中华结核和呼吸杂志,2013,36(4): 255-264.[2] 余苏云,高习文,颜志军,等. TNF-α+489 基因多态性与慢性阻塞性肺疾病急性加重表型的相关性研究[J]. 临床肺科杂志,2018,23(8): 57-61.[3] Barnes P J. Inflammatory mechanisms in patients withchronic obstructive pulmonary disease[J] . Journal ofAllergy and Clinical Immunology,2016, 138(1): 16-27.[4] Yu S, Gao X, Yan Z. Relationship between gene polymorphismsof tumor necrosis factor-α-308 and phenotypes of acuteexacerbation of chronic obstructive pulmonary diseases[J].China Medical Abstracts(Internal Medicine), 2016, 39(2):203.[5] 郭进秋. 三子养亲汤加味治疗慢性阻塞性肺疾病急性加重期(痰浊壅肺证)的临床观察[D]. 成都: 成都中医药大学,2017.[6] Liang D W, Zhang Z H, Huang Q, et al. Investigation ofPCT, WBC and CRP for auxiliary diagnosing value ofbacteremia[J]. China Modern Medicine, 2014, 21(22):99-100.[7] 中国医药教育协会感染疾病专业委员会.感染相关生物标志物临床意义解读专家共识[J]. 中华结核和呼吸杂志,2017,40(4): 243-257.[8] 苗云霞,阎磊. 血清降钙素原水平指导 AECOPD 抗菌药物应用的价值[J]. 贵阳医学院学报,2015,40(12): 1374-1376.[9] 瞿媛,代君,周建中,等. 中西医结合治疗慢性阻塞性肺疾病急性发作期痰浊痹阻型疗效观察[J]. 实用中医药杂志,2017(33): 1412.[10] 张毓珍. 血清降钙素原检测在急诊感染性发热治疗中的应用观察[J]. 世界最新医学信息文摘,2019,19(37): 169,182.[11] 张文斌,雷文汇,冯英凯. 竹叶石膏汤合清气化痰丸加减治疗急性加重期慢性阻塞性肺疾病[J]. 中国实验方剂学杂志,2017(11): 198-203.[12] 陈英. 清金化痰汤通过中性粒细胞弹性蛋白酶干预AECOPD 气道粘液高分泌的临床及实验研究[D]. 北京:北京中医药大学,2016.[13] Barnes P J. Inflammatory mechanisms in patients withchronic obstructive pulmonary disease[J]. Journal ofAllergy and Clinical Immunology, 2016, 138(1): 16-27.[14] Aidan B, May W G, Elizabeth S. Neutrophilic inflammationin the pathogenesis of chronic obstructive pulmonarydisease[J]. COPD: Journal of Chronic ObstructivePulmonary Disease, 2018, 15(4): 1-13.[15] Van D E M, Sule C, Menzen M H, et al. Elastase-inducedparenchymal disruption and airway hyper responsiveness inmouse precision cut Lung Slices: Toward an Ex vivo COPDModel[J]. Frontiers in Physiology, 2017(7): 657.[16] Pascual-González Y,Lopez-Sanchez M,Dorca J,et al.Defining the role of neutrophil-to-lymphocyte ratio inCOPD: a systematic literature review[J]. InternationalJournal of COPD, 2018(13): 3651-3662.[17] Paliogiannis P,Fois A G,Sotgia S,et al. Neutrophil tolymphocyte ratio and clinical outcomes in COPD: recentevidence and future perspectives[J]. European RespiratoryReview, 2018, 27(147): 170113.[18] 徐象辉. 清金化痰汤加减联合西医治疗肺热壅盛型AECOPD 的临床疗效观察[D]. 广州: 广州中医药大学,2017.[19] 冯莎莎. 清肺祛痰方治疗慢性阻塞性肺疾病急性加重期(痰热郁肺证)患者的临床疗效研究及对相关炎性标记物的影响[ D]. 合肥: 安徽中医药大学,2018.[20] 王中野. 全血 C 反应蛋白与血常规联合检验在儿科细菌性感染性疾病中的诊断价值分析[J]. 中西医结合心血管病电子杂志,2018,6(34): 204,206.[21] 郑宇红. 清金化浊法对慢性阻塞性肺疾病急性加重期血清炎性标志物的影响[D]. 北京: 北京中医药大学,2016.[22] 向菊英. 定喘汤合清气化痰丸加减治疗痰热蕴肺型慢性阻塞性肺疾病急性加重期的临床疗效[J]. 临床合理用药杂志,2018(12): 103-104.[23] Haas M, Kaup F J, Neumann S. Canine pyometra:a modelfor the analysis of serum CXCL8 in inflammation[J].Journal of Veterinary Medical Science, 2016, 78(3):375-381.[24] Williams A E, José R J, Mercer P F, et al. Evidence forchemokine synergy during neutrophil migration inARDS[J]. Thorax, 2017, 72(1): 66-73.[25] 魏光明,刘素香,白宇望. 麻杏石甘汤加味治疗外寒内热证慢阻肺急性加重期的临床效果[J]. 临床医学研究与实践,2019,4(10): 127-128,139.[26] 李玲. 益气活血化痰法对 COPD 稳定期肺脾气虚证患者疗效观察及对大鼠气道炎症指标的影响[D]. 广州: 广州中医药大学,2015.[27] 景璇,郭洁,张嘉,等. 加味麻杏石甘汤配合穴位贴敷治疗老年慢性阻塞性肺病急性加重期患者的效果及对肺功能和肿瘤坏死因子-α、白细胞介素-8表达的影响[J]. 中国老年学杂志,2017(1): 132-133.[28] 陈文霖,刘笑静. 化痰止咳合剂对 AECOPD 患者血清SAA、IL-6、IL-1β 和肺功能的影响[J]. 中国现代应用药学,2017(3): 132-135.[29] Liu H M, Liu Y T, Zhang J, et al. Bone marrowmesenchymal stem cells ameliorate lung injury throughanti-inflammatory and antibacterial effect in COPD mice[J].Journal of Huazhong University of Science andTechnology(Medical Sciences), 2017(4): 32-40.[30] 符岛,符裕,林德厚. 慢性阻塞性肺疾病急性加重期患者认知状况的影响因素探讨[J]. 中南医学科学杂志,2016,44(2): 48-51.[31] 吴娟. 慢性阻塞性肺疾病患者血清可溶性髓样细胞触发受体-1、肿瘤坏死因子-α 与白介素-6 的检测及意义[D].广州: 南方医科大学,2016.[32] Singh S, Verma S K, Kumar S, et al. Correlation of severityof chronic obstructive pulmonary disease with potentialbiomarkers[J].Immunology Letters, 2018(196): 1-10.[33] Ardestani M E, Zaerin O. Role of serum interleukin 6albumin and C-reactive protein in COPD patients[J].Tanaffos, 2015, 14 (2): 134-140.[34] Alireza S, Yunes P, Saeed S, et al. Relationship of serumlevels of interleukin6,interleukin8,and C- reactive proteinwith forced expiratory volume in first second in the patientswith mustard lung and chronic obstructive pulmonarydiseases: systematic review and meta-analysis[J]. Advancesin Dermatology and Allergology, 2017(3): 192-198.[35] Meshram P L, Shinde S, Ramraje N, et al. Study ofinflammatory markers and BODE index in chronicobstructive pulmonary disease[J]. Lung India, 2018, 35(1):37.[36] 郭义娟,朱晖,韩永生,等. 慢性阻塞性肺疾病稳定期患者血清 PCT、IL-6、hs-CRP、PSP/Reg 水平变化对病情的预测价值[J]. 解放军预防医学杂志,2018,36(4):34-37.[37] 周璇. 清肺化痰汤对 COPD 急性加重期痰热郁肺证患者的临床研究[D]. 南宁: 广西中医药大学,2018.[38] 徐瑜,罗百灵. 慢性阻塞性肺疾病急性加重期患者血清hs-CRP、CA-125 和 IL-6 水平变化及临床意义[J]. 临床肺科杂志,2017(3): 458-460.